Gupta C, Singh M
Department of Pediatric Endocrinology, Children's Hospital of Pittsburgh, Rangos Research Center, Pennsylvania 15213, USA.
Endocrinology. 1996 Feb;137(2):705-11. doi: 10.1210/endo.137.2.8593821.
We have shown previously that epidermal growth factor (EGF) plays a role in testosterone-dependent fetal Wolffian duct differentiation. To further assess the role for EGF, we determined whether EGF gene expression was modulated in response to male reproductive tract differentiation. The expression of EGF messenger RNA (mRNA) was measured by an RT-PCR assay using primer pairs spanning the coding sequence of 3228 nucleotide (nt) to 3401 nt. Using the RT-PCR reaction, an amplimer of the expected size, 173 bp, was detected in the fetal male reproductive tract. The amplimer hybridized with a radioactive probe representing an internal sequence of the amplified product and was digested by the restriction enzyme HaeIII, which has an unique cleavage site at 3365 nt. The level of EGF mRNA at different stages of sexual differentiation was measured by a newly developed quantitative competitive RNA PCR (QCPCR) assay for EGF mRNA. The assay was sensitive and reproducible within a linear range of amplification with 5 x 10(4) to 140 x 10(4) copies of mRNA. Using the quantitative competitive RNA PCR we found that the level of EGF mRNA was higher in the male reproductive tract than that in the female reproductive tract. Exposure to testosterone (40 mg/kg.day) during days 13-17 of gestation induced the Wolffian duct in the female fetuses and resulted in stimulation of EGF-mRNA expression. Similarly, an antiandrogen receptor, flutamide (100 mg/kg.day) exposure during days 13-17 of gestation inhibited male reproductive tract differentiation and resulted in inhibition of EGF-mRNA expression. Moreover, during the differentiation of the male reproductive tract there was a biphasic increase in the level of EGF-mRNA, first at day 14 of gestation, the period of onset of testicular activity and Wolffian duct morphogenesis, and second at day 18 of gestation, corresponding to onset of differentiation of the urogenital sinus, epididymal duct, and seminal vesicle. Thus, it appears that testosterone-induced male sexual differentiation is accompanied by an increase in EGF gene expression.
我们之前已经表明,表皮生长因子(EGF)在睾酮依赖性胎儿中肾管分化中发挥作用。为了进一步评估EGF的作用,我们确定EGF基因表达是否会响应雄性生殖道分化而受到调节。通过使用跨越3228个核苷酸(nt)至3401 nt编码序列的引物对的逆转录聚合酶链反应(RT-PCR)测定法来测量EGF信使核糖核酸(mRNA)的表达。使用RT-PCR反应,在胎儿雄性生殖道中检测到预期大小为173 bp的扩增子。该扩增子与代表扩增产物内部序列的放射性探针杂交,并被限制性内切酶HaeIII消化,该酶在3365 nt处有一个独特的切割位点。通过新开发的用于EGF mRNA的定量竞争性RNA PCR(QCPCR)测定法来测量性分化不同阶段的EGF mRNA水平。该测定法在5×10⁴至140×10⁴拷贝mRNA的线性扩增范围内灵敏且可重复。使用定量竞争性RNA PCR,我们发现雄性生殖道中EGF mRNA的水平高于雌性生殖道中的水平。在妊娠第13至17天期间暴露于睾酮(40 mg/kg·天)可诱导雌性胎儿的中肾管,并导致EGF-mRNA表达受到刺激。同样,在妊娠第13至17天期间暴露于抗雄激素受体氟他胺(100 mg/kg·天)会抑制雄性生殖道分化,并导致EGF-mRNA表达受到抑制。此外,在雄性生殖道分化过程中,EGF-mRNA水平呈双相增加,首先在妊娠第14天,即睾丸活动和中肾管形态发生开始的时期,其次在妊娠第18天,对应于泌尿生殖窦、附睾管和精囊分化的开始。因此,似乎睾酮诱导的雄性性别分化伴随着EGF基因表达的增加。